Pap Smear, HPV and HPV Vaccine. Peggy JB Scurry, MD, Ph.D. FACOG, FACS Assistant Professor & Chief of Gynecology Howard University Department of Obstetrics & Gynecology http://pscurrymd.scurtek.net National Medical Association Annual Conference August 2007. Objectives.
53.8% 78.3% 18.2%
Manos MM. et al. JAMA. 1999:281:1605-1610.
Clavel C. et al. Brit J Cancer. 2001:89:1616-1623.
HPV & Cervical Cancer, Merk Vaccine Div.,2005
they required a longer time to clear, i.e. 12 mos and 3 yrs when compared to adults
Saslow D. et al. CANCER 52(6)342-362.
Meikert PW. Et al. Int J Cancer. 1993.53.919-923.
LESS Than 3 in 100,000
Excess risk of cervical cancer
Podofilox 0.5% solution or gel
Imiquimod 5% cream
Trichloroacetic Acid or Bichloroacetic Acid 80%-90%
Surgical Removal by electrosurgeryGenital Warts - Recommended Treatment Regimens
The vaccine will likely steadily decrease the rate of abnormal paps that are important, as an increasing proportion of women are vaccinated against the 2 most common types in high-grade CIN
Colposcopies and cervical treatment will decline in number with the proportion of the populated vaccinated
--D. All of the above.
B. Number of full-term pregnancies
C. Number of life time sexual partners
A. HPV 6 and 11
B. HPV 31 and 35
C. HPV 45 and 51
D. HPV 16 and 18